Pharmaron Beijing Co., Ltd. (SHE:300759)
China
· Delayed Price · Currency is CNY 29.75
-1.17 (-3.78%)
Apr 29, 2026, 3:04 PM CST
Pharmaron Beijing Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 52,394 | 47,162 | 41,846 | 47,371 | 76,952 | 106,395 | Upgrade
|
| Market Cap Growth | 18.69% | 12.70% | -11.66% | -38.44% | -27.67% | 12.84% | Upgrade
|
| Enterprise Value | 57,174 | 51,840 | 45,726 | 51,401 | 80,058 | 105,734 | Upgrade
|
| Last Close Price | 30.92 | 28.43 | 25.49 | 28.45 | 44.16 | 60.94 | Upgrade
|
| PE Ratio | 32.57 | 28.34 | 23.33 | 29.59 | 55.98 | 64.05 | Upgrade
|
| Forward PE | 23.69 | 24.72 | 26.22 | 25.72 | 35.75 | 59.23 | Upgrade
|
| PS Ratio | 3.59 | 3.35 | 3.41 | 4.11 | 7.50 | 14.29 | Upgrade
|
| PB Ratio | 3.06 | 3.00 | 2.94 | 3.58 | 7.10 | 10.33 | Upgrade
|
| P/TBV Ratio | 4.46 | 4.59 | 4.16 | 5.27 | 10.90 | 14.50 | Upgrade
|
| P/FCF Ratio | 187.02 | 85.44 | 78.07 | - | - | - | Upgrade
|
| P/OCF Ratio | 17.63 | 14.64 | 16.24 | 17.20 | 35.91 | 51.70 | Upgrade
|
| PEG Ratio | 1.52 | 1.86 | 2.99 | 1.12 | 1.16 | 1.87 | Upgrade
|
| EV/Sales Ratio | 3.92 | 3.68 | 3.73 | 4.46 | 7.80 | 14.20 | Upgrade
|
| EV/EBITDA Ratio | 17.37 | 16.99 | 17.61 | 21.15 | 35.94 | 57.09 | Upgrade
|
| EV/EBIT Ratio | 27.28 | 25.35 | 26.60 | 30.42 | 48.04 | 73.04 | Upgrade
|
| EV/FCF Ratio | 204.08 | 93.92 | 85.31 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.42 | 0.45 | 0.42 | 0.73 | 0.56 | 0.51 | Upgrade
|
| Debt / EBITDA Ratio | 2.16 | 2.19 | 2.16 | 3.71 | 2.59 | 2.72 | Upgrade
|
| Debt / FCF Ratio | 25.35 | 12.76 | 11.15 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.24 | 0.28 | 0.20 | 0.23 | 0.30 | -0.09 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.32 | 1.44 | 1.12 | 1.23 | 1.46 | -0.48 | Upgrade
|
| Net Debt / FCF Ratio | 14.72 | 7.97 | 5.43 | -26.63 | -4.04 | 25.68 | Upgrade
|
| Asset Turnover | 0.55 | 0.55 | 0.49 | 0.49 | 0.53 | 0.49 | Upgrade
|
| Inventory Turnover | 6.69 | 7.11 | 7.60 | 7.23 | 7.55 | 9.92 | Upgrade
|
| Quick Ratio | 0.75 | 0.70 | 1.44 | 2.58 | 1.31 | 2.58 | Upgrade
|
| Current Ratio | 1.08 | 0.93 | 1.80 | 2.98 | 1.67 | 2.90 | Upgrade
|
| Return on Equity (ROE) | 9.99% | 10.38% | 12.48% | 13.14% | 12.80% | 16.85% | Upgrade
|
| Return on Assets (ROA) | 4.95% | 5.01% | 4.26% | 4.50% | 5.36% | 5.97% | Upgrade
|
| Return on Invested Capital (ROIC) | 8.19% | 8.92% | 8.45% | 9.59% | 11.51% | 15.80% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.40% | 10.90% | 8.70% | 7.40% | 10.10% | 9.40% | Upgrade
|
| Earnings Yield | 3.23% | 3.53% | 4.29% | 3.38% | 1.79% | 1.56% | Upgrade
|
| FCF Yield | 0.53% | 1.17% | 1.28% | -0.24% | -1.05% | -0.03% | Upgrade
|
| Dividend Yield | 0.68% | 0.70% | 0.78% | 0.70% | 0.45% | 0.33% | Upgrade
|
| Payout Ratio | 31.73% | 31.92% | 30.24% | 27.78% | 29.45% | 17.14% | Upgrade
|
| Buyback Yield / Dilution | 0.11% | 0.11% | 0.11% | 0.05% | 2.40% | -1.97% | Upgrade
|
| Total Shareholder Return | 0.79% | 0.81% | 0.89% | 0.76% | 2.85% | -1.64% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.